CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Completed
Galderma R&D
Phase 3
2012-04-01
Study objectives:
- To compare efficacy and safety of Ivermectin 1% cream versus metronidazole 0.75% cream
in subjects with papulopustular rosacea after 16-week topical treatment.
- And to compare, for subjects initially successfully treated by 16 weeks treatment,
Ivermectin 1 % cream versus metronidazole 0.75% cream during a 36-week extension period
by assessing, the time of first relapse, the relapse rate, and the number of days free
of treatment
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Completed
Galderma
Phase 4
2015-12-01
The main objective of this study is to evaluate the efficacy of Ivermectin 1% cream (IVM)
associated with Brimonidine 0.33% gel (Br) compared with the association of their respective
vehicles in the treatment of moderate to severe rosacea.
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Completed
Galderma R&D
Phase 4
2015-12-01
The main objective of this study is to evaluate the efficacy of Ivermectin 1% cream (IVM)
associated with Brimonidine 0.33% gel (Br) compared with the association of their respective
vehicles in the treatment of moderate to severe rosacea.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
